Search
Now showing items 41-50 of 164
Biomarkers of prehipertension / Biomarkeri prehipertenzije
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Prehypertension, which was defined as a systolic blood pressure (SBP) between 120 and 139 mmHg or a diastolic blood pressure (DBP) between 80 and 89 mmHg is shown to be associated with a twofold higher risk of cardiovascular ...
Nanomaterials in cosmetic products: Functionality and safety issues / Nanomaterijali u kozmetičkim proizvodima - opravdanost primene i bezbednost
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
Nanomaterials in cosmetic products include particles of active ingredients (AI) (nanocrystals, nanoparticles) (e.g., ultrafine/nanoparticles titanium dioxide, zinc oxide, silver, gold) as well as a variety of nanocarriers ...
Nasal preparations: Conventional and advanced pharmaceutical dosage forms / Preparati za primenu na sluznicu nosa - konvencionalni i savremeni farmaceutski oblici
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
Nasal dosage forms (nasal preparations) are traditionally used for local drug delivery, often for cold and flu symptoms' therapy. Apart from conventional dosage forms such as nasal drops, ointments and gels and aqueous ...
Excipients functionality: Importance and compendial status / Funkcionalnost ekscipijenasa - značaj i farmakopejski status
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
Traditional understanding of excipients as simple, inert and inactive ingredients of pharmaceutical preparations was changed when it became clear that they may significantly affect quality, safety and efficacy of pharmaceutical ...
Pharmacogenetics and pharmacogenomics: The impact of the single nucleotide polymorphisms in drug response / Farmakogenetika i farmakogenomika - uticaj jednonukleotidnih polimorfizama na odgovor na lekove
(Savez farmaceutskih udruženja Srbije, Beograd, 2015)
Individual variation in response to drugs is an important clinical problem, which ranges from failure to respond to the drug, over adverse reactions to drugs, to interactions among drugs being administered concurrently. ...
Pharmaceutical preparations in prevention and therapy of venous disorders: Pharmaceutical technology aspects / Farmaceutsko-tehnološki aspekti preparata za prevenciju i lečenje poremećaja venske cirkulacije
(Savez farmaceutskih udruženja Srbije, Beograd, 2013)
The main purposes of pharmacotherapy in deep and superficial venous thrombosis are prevention and therapy of acute and chronic venous insufficiency as well as complications such as pulmonary embolism, dermatoses, venous ...
Pharmacoeconomic evaluation of providing pharmacist-managed anticoagulation service to patients on warfarin / Farmakoekonomska evaluacija pružanja farmaceutske usluge pacijentima na antikoagulantnoj terapiji varfarinom
(Savez farmaceutskih udruženja Srbije, Beograd, 2016)
It has been determined that Pharmacist-Managed Anticoagulation Service (PMAS) for patients on warfarin improves anticoagulation control and decreases the rate of bleeding, thus reducing the overall health care costs. This ...
Drugs for rare diseases: An example of modified glucocerebrosidase / Lekovi za retke bolesti - primer modifikovane glukocerebrozidaze
(Savez farmaceutskih udruženja Srbije, Beograd, 2011)
To date, circa 5000 rare diseases have been defined, which in sum affect approximately 6% of total population. The development of drugs for rare diseases is hampered by the limitation of specific knowledge availability and ...
Development of therapeutic monoclonal antibodies: From the mouse to the human / Razvoj monoklonskih antitela za terapijsku primenu - od mišjih do humanih
(Savez farmaceutskih udruženja Srbije, Beograd, 2012)
Therapeutical monoclonal antibodies (mAbs) represent one of the fastest growing area of the pharmaceutical industry. High target specificity and specific molecular structure are features that make antibodies attractive ...
3D-QSAR modeling and pharmacophore study of serotonin 5HT-₂A receptors antagonists / 3D-QSAR modelovanje i analiza farmakofore antagonista serotoninskih 5-HT2A receptora
(Savez farmaceutskih udruženja Srbije, Beograd, 2017)
Creation of a statistically reliable 3D-QSAR (Quantitative Structure Activity Relationships) model enables definition of the structure of the pharmacophore for antagonists of serotonin 5-HT2A receptors and selection of the ...